Allstate (NYSE:ALL) PT Raised to $146.00

Allstate (NYSE:ALL) had its price target lifted by research analysts at Wells Fargo & Company from $145.00 to $146.00 in a report issued on Thursday, Benzinga reports. The brokerage presently has an “underweight” rating on the insurance provider’s stock. Wells Fargo & Company‘s target price points to a potential downside of 12.48% from the company’s current price.

ALL has been the subject of several other reports. TD Cowen began coverage on shares of Allstate in a research note on Wednesday, January 10th. They issued an “outperform” rating and a $193.00 target price for the company. UBS Group increased their target price on shares of Allstate from $171.00 to $185.00 and gave the stock a “buy” rating in a research note on Monday, February 12th. Keefe, Bruyette & Woods lifted their price target on Allstate from $181.00 to $189.00 and gave the company an “outperform” rating in a research note on Wednesday. Evercore ISI upped their price target on Allstate from $166.00 to $173.00 and gave the stock an “in-line” rating in a report on Thursday. Finally, Jefferies Financial Group raised Allstate from a “hold” rating to a “buy” rating and raised their price objective for the company from $130.00 to $180.00 in a report on Tuesday, January 9th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Allstate presently has a consensus rating of “Moderate Buy” and an average price target of $172.59.

Allstate Stock Performance

NYSE ALL opened at $166.81 on Thursday. The firm has a market capitalization of $43.88 billion, a P/E ratio of -134.52, a PEG ratio of 0.42 and a beta of 0.52. The stock has a 50-day simple moving average of $163.04 and a two-hundred day simple moving average of $145.13. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.37 and a current ratio of 0.37. Allstate has a fifty-two week low of $100.57 and a fifty-two week high of $174.57.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Thursday, February 8th. The insurance provider reported $5.82 earnings per share for the quarter, beating the consensus estimate of $3.87 by $1.95. Allstate had a positive return on equity of 2.67% and a negative net margin of 0.33%. The company had revenue of $14.83 billion during the quarter, compared to analysts’ expectations of $12.69 billion. During the same period last year, the business earned ($1.36) earnings per share. Allstate’s quarterly revenue was up 8.7% on a year-over-year basis. On average, equities analysts forecast that Allstate will post 13.41 earnings per share for the current year.

Insider Transactions at Allstate

In related news, insider John E. Dugenske sold 31,000 shares of the business’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the transaction, the insider now directly owns 63,731 shares in the company, valued at $10,847,016.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider John E. Dugenske sold 31,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the completion of the sale, the insider now directly owns 63,731 shares in the company, valued at $10,847,016.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO John C. Pintozzi sold 4,000 shares of Allstate stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total value of $637,880.00. Following the transaction, the chief accounting officer now owns 10,736 shares in the company, valued at approximately $1,712,069.92. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On Allstate

Institutional investors have recently bought and sold shares of the company. Gradient Investments LLC increased its holdings in shares of Allstate by 1.6% during the 4th quarter. Gradient Investments LLC now owns 4,130 shares of the insurance provider’s stock worth $578,000 after buying an additional 66 shares during the last quarter. Brighton Jones LLC increased its stake in Allstate by 1.9% during the fourth quarter. Brighton Jones LLC now owns 3,862 shares of the insurance provider’s stock worth $541,000 after acquiring an additional 71 shares during the last quarter. SVB Wealth LLC raised its position in Allstate by 1.2% in the fourth quarter. SVB Wealth LLC now owns 6,169 shares of the insurance provider’s stock valued at $864,000 after purchasing an additional 72 shares during the period. Apollon Wealth Management LLC lifted its stake in shares of Allstate by 2.5% in the 4th quarter. Apollon Wealth Management LLC now owns 3,214 shares of the insurance provider’s stock valued at $436,000 after purchasing an additional 78 shares during the last quarter. Finally, AdvisorNet Financial Inc grew its holdings in shares of Allstate by 1.5% during the 4th quarter. AdvisorNet Financial Inc now owns 5,384 shares of the insurance provider’s stock worth $754,000 after purchasing an additional 82 shares during the period. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.